×
Newsmax TV & Webwww.newsmax.comFREE - In Google Play
VIEW
×
Newsmax TV & Webwww.newsmax.comFREE - On the App Store
VIEW
Tags: Diabetes | diabetes | treatment | Xigduo | pill

2-in-1 Diabetes Pill OKd by FDA

Thursday, 30 October 2014 08:19 AM

A new two-in-one diabetes pill from AstraZeneca has been approved by U.S. regulators, the British drugmaker said on Thursday.
 
The green light from the Food and Drug Administration is for Xigduo XR, which combines the company's recently launched diabetes treatment dapagliflozin with an older kind of medicine called metformin.

Xigduo XR is the first once-daily tablet combining a so-called SGLT2 inhibitor drug and metformin to win U.S. approval.

© 2021 Thomson/Reuters. All rights reserved.


Health-News
A new two-in-one diabetes pill from AstraZeneca has been approved by U.S. regulators, the British drugmaker said on Thursday. The green light from the Food and Drug Administration is for Xigduo XR, which combines the company's recently launched diabetes treatment...
diabetes, treatment, Xigduo, pill
68
2014-19-30
Thursday, 30 October 2014 08:19 AM
Newsmax Media, Inc.
Join the Newsmax Community
Register To Comment Login To Comment
Please review Community Guidelines before posting a comment.
 
Find Your Condition
TOP

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved
NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved